WallStreetZenWallStreetZen

NASDAQ: SGMT
Sagimet Biosciences Inc Stock Ownership - Who owns Sagimet Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sagimet Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thierry ChaucheChief Financial Officer2026-02-101,312$5.36
$7.03kSell
David HappelPresident CEO2026-02-1012,101$5.36
$64.86kSell
Eduardo Bruno MartinsChief Medical Officer2026-02-103,640$5.36
$19.51kSell
Elizabeth RozekChief Legal Admin. Officer2026-02-102,622$5.36
$14.05kSell
George KembleExecutive Chairman2025-11-2037,688$7.69
$289.97kSell
Eduardo Bruno MartinsChief Medical Officer2025-07-218,277$9.14
$75.61kSell
David HappelPresident CEO2025-07-2165,478$9.14
$598.14kSell
Elizabeth RozekGeneral Counsel and CCO2025-07-2110,780$9.14
$98.48kSell

1 of 1

SGMT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMT insiders and whales buy or sell their stock.

SGMT Shareholders

What type of owners hold Sagimet Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Kerins4.93%3,013,414$19.65MInsider
Forest Baskett4.92%3,011,575$19.64MInsider
Scott D. Sandell4.92%3,007,272$19.61MInsider
New Enterprise Associates 13 LP4.90%3,000,275$19.56MInsider
Nea Partners 13 Limited Partnership4.90%3,000,275$19.56MInsider
Beth C. Seidenberg3.32%2,031,118$13.24MInsider
Kpcb Pbd Associates LLC3.10%1,899,475$12.38MInsider
Jinzi Jason Wu2.70%1,654,701$10.79MInsider
Vanguard Capital Management LLC1.80%1,098,919$7.16MInstitution
Woodline Partners LP1.64%1,000,943$6.53MInstitution

1 of 3

SGMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMT21.83%35.89%Net Selling
MNPR24.69%75.31%Net SellingNet Selling
AUTL50.51%0.53%
OCGN32.73%10.52%Net BuyingNet Buying
IPSC76.60%23.40%Net SellingNet Selling
View Top Biotech Stocks

Sagimet Biosciences Stock Ownership FAQ

Who owns Sagimet Biosciences?

Sagimet Biosciences (NASDAQ: SGMT) is owned by 21.83% institutional shareholders, 35.89% Sagimet Biosciences insiders, and 42.28% retail investors. Patrick J. Kerins is the largest individual Sagimet Biosciences shareholder, owning 3.01M shares representing 4.93% of the company. Patrick J. Kerins's Sagimet Biosciences shares are currently valued at $19.59M.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.